The American Thoracic Society/Pulmonary Hypertension Association Partnership Grant for
Pulmonary Hypertension
Description: ATS/Pulmonary Hypertension Association Research Grant (2 grants available in this category).
Deadline:
A new timeline line for this grant will be announced in December 2009. Please check back then for updates on the Letter of Intent (LOI) and grant submission deadlines
This is a joint research award that will be co-funded by the ATS and the Pulmonary Hypertension Association, one of the ATS Public Advisory Roundtable members. Two research grants will be awarded to support novel studies of the diagnosis, pathogenesis, treatment or outcomes of pulmonary hypertension. Applicants may request up to $50,000/year for 2 years for salaries, supplies or a combination of these two. Applicants must meet the criteria listed below on this website. A primary goal of the ATS research program is to enable new faculty-level investigators to make the transition to careers as established investigators. Partnerships between junior and senior investigators are strongly encouraged, particularly for new investigators who are within 1 to 5 years of the completion of their training. Both US and non-US based investigators are encouraged to apply. One of the investigators must be an ATS member at the time of application, and the Principal Investigator must be an ATS member at the time that the grant is awarded. Indirect costs will not be paid to the sponsoring institution.
Award Winners
2009
Ari Zaiman, MD, PhD
Johns Hopkins University School of Medicine
Research: "Inhibition of TGF beta signaling in endothelial cells: Role in Pulmonary Hypertension"
Mentor/Sponsor: Hal Dietz, MD
January 2009 -December 2010
Lunyin Yu, MD
Massachusetts General Hospital
Research: "Role of NHE1 gene in development of pulmonary hypertension and vascular remodeling"
Mentor/Sponsor: Charles A. Hales, MD
January 2009 -December 2010
2008
Kewal Asosingh, PhD
Cleveland Clinic Foundation
Senior Investigator: Serpil Ezrum, MD
“Role of pulmonary vascular wall resident endothelial progenitors and circulating bone marrow-derived angiogenic precursors in idiopathic pulmonary arterial hypertension”
January 1, 2008- December 31, 2009
Qing Lu, DVM, PhD
Brown University
Senior Investigators: James R. Klinger, MD, Elizabeth O. Harrington, PhD
“TGF-beta1 and pulmonary artery hypertension”
January 1, 2008 –December 31, 2009
2007
Namasivayam Ambalavanan, MBBS, MD University of Alabama at Birmingham
Senior Investigators: Yiu-Fai Chin, PhD and James Hawgood, MD
“Transforming Growth Factor-β and Effects of Hypoxia on the Newborn Lung”
Term: January 1, 2007 – December 31, 2008
Arlin Brice Blood, PhD Loma Linda University School of Medicine
Senior Investigator: Gordon Power, MD
“The Interaction of Nitric Oxide and Hemoglobin in Regulation of Pulmonary Vascular Tone”
Term: January 1, 2007 – December 31, 2008
2006
Xinqi Wu, PhD
Children’s Hospital Boston
Senior Investigator: Stella Kourembanas, MD
“Hypoxic regulation of BMP signaling and the role of Id1 in the development of pulmonary hypertension”
Term: January 1, 2006 – December 31, 2007
Todd Bull, MD
University of Colorado
Senior Investigators: Thomas Campbell, MD and Mark Grace, MD
“The role of Kaposi’s sarcoma herpesvirus in the development of severe pulmonary hypertension”
Term: January 1, 2006 – December 31, 2007
The
information provided on the PHA website is provided for general information
only. It is not intended as legal, medical or other professional
advice, and should not be relied upon as a substitute for consultations
with qualified professionals who are familiar with your individual
needs.
